Amalia M. Issa PhD

Dr. Amalia M. Issa is Professor of Health Policy and Public Health and Chair of the Department of Health Policy and Public Health and the Director of the Program in Personalized Medicine and Targeted Therapeutics. The Program was founded in 2001, by Dr. Issa, as one of the first centers focused on pharmacogenomics and personalized medicine to advance the science and translation of personalized medicine through state-of-the-art research and education. Dr. Issa has developed a unique area of translational research focused on pharmacogenomics and personalized medicine applications, and how they will be translated and integrated into health care delivery and health systems. Her research is positioned at the nexus of epidemiology/health services research and molecular science, and she leads an interdisciplinary team of scientists who are actively engaged in research aimed at the effective translation of the science of pharmacogenomics and personalized medicine from the laboratory bench to the bedside and to the community and policy. Dr. Issa and her team are committed to developing the evidence base for, promoting informed decision making about, and accelerating knowledge translation of personalized medicine applications into meaningful health outcomes. Dr. Issa is nationally and internationally recognized in the field of personalized medicine, and has published numerous papers, many widely cited, in pharmacogenomics and personalized medicine, clinical pharmacology, neuropharmacology and drug safety. She has served or is serving as the principal investigator on a number of funded projects, and is a reviewer for several scientific journals, granting agencies. Dr. Issa serves on editorial boards and in leadership positions in several professional associations, and has received many awards and honors for her work.